Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.93 USD | +1.65% | -2.95% | -2.38% |
Financials (USD)
Sales 2024 * | 76.38M | Sales 2025 * | 52.83M | Capitalization | 603M |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -141M | EV / Sales 2024 * | 5.78 x |
Net cash position 2024 * | 161M | Net cash position 2025 * | 67.89M | EV / Sales 2025 * | 10.1 x |
P/E ratio 2024 * |
-4.88
x | P/E ratio 2025 * |
-4.62
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.8% |
Latest transcript on Wave Life Sciences Ltd.
1 day | +1.65% | ||
1 week | -2.95% | ||
1 month | -20.10% | ||
3 months | +14.12% | ||
6 months | -8.36% | ||
Current year | -2.38% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Bolno
CEO | Chief Executive Officer | 50 | 13-11-30 |
Kyle Moran
DFI | Director of Finance/CFO | 54 | 14-06-30 |
Chandra Vargeese
CTO | Chief Tech/Sci/R&D Officer | 63 | 14-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
CHM | Chairman | 56 | 16-11-09 |
Mark Corrigan
BRD | Director/Board Member | 66 | 19-09-03 |
Adrian Rawcliffe
BRD | Director/Board Member | 52 | 17-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +1.51% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 4.93 | +1.65% | 494,822 |
24-04-29 | 4.85 | +4.08% | 503,804 |
24-04-26 | 4.66 | -1.69% | 407,036 |
24-04-25 | 4.74 | -5.39% | 397,715 |
24-04-24 | 5.01 | -1.38% | 430,676 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.38% | 593M | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- WVE Stock